Wafik S. El-Deiry: The slippery slope in the potential of AI making judgements on patients’ behalf

Wafik S. El-Deiry shared a post by JAMA Internal Medicine, on X:

“I worry about the slippery slope and whether finances will factor into this in the future. Haste in judgements could be impacted by lack of clarity about what may be irreversible vs reversible. I’ve always understood statistics apply to populations, not individuals some of whom ‘beat the odds.'”

Quoting JAMA Internal Medicine‘s post:

“In this Viewpoint, the authors explore how artificial intelligence could support surrogate decision-makers while addressing some of the attendant epistemic and moral challenges.

‘Can Artificial Intelligence Speak for Incapacitated Patients at the End of Life?‘

Authors: Teva D. Brender, Alexander K. Smith, Brian L. Block.”

Source: Wafik S. El-Deiry/X and JAMA Internal Medicine/X

Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.